November 8, 2012
Kyorin Holdings said on November 7 that it has discontinued the development of its DPP-4 (dipeptidyl peptidase-4) inhibitor KRP-104 after its search for a tie-up partner to codevelop the compound ended in vain. The company has already completed its PII...read more